ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1349	National Cancer Institute	Html	en	Colon Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of colon cancer.	metastatic colorectal carcinoma 0.379719 Surg Oncol Clin 0.28139 Engl J Med 0.307023 trial 0.267885 Ann Surg 0.318122 colorectal cancer risk 0.348524 asymptomatic colorectal cancer 0.315392 metastatic colorectal cancer 0.735027 randomized phase 0.263484 colorectal metastasis 0.289879 colorectal cancer 0.918186 solitary colorectal liver 0.301665 progressive colorectal cancer 0.31143 Natl Cancer Inst 0.281801 colorectal metastases 0.313181 nonpolyposis colorectal carcinoma 0.307382 Clin Cancer Res 0.283288 refractory metastatic colorectal 0.315102 et al. 0.431822 familial colorectal cancer 0.339414 colorectal secondaries 0.290645 colorectal cancer patients 0.339629 colorectal liver metastases 0.36614 colorectal cancer survivors 0.325228	colorectal cancer-specific mortality 0.322283 untreated metastatic colorectal 0.318138 wild-type metastatic colorectal 0.314285 Colorectal carcinoma survival 0.308216 colorectal hepatic metastases 0.334861 advanced colorectal cancer 0.418679 Colorectal lung metastases 0.315994 irinotecan-refractory metastatic colorectal 0.314278 advanced colorectal carcinoma 0.299668 colon cancer patients 0.266011 recurrent colorectal cancer 0.311799 colorectal adenocarcinoma 0.293617 colorectal cancer incidence 0.338171 colorectal cancer disparities 0.338169 occult colorectal cancer 0.324742 colorectal cancer rates 0.338223 hepatic resection 0.263128 Colorectal Study Group 0.29718 Abstract 0.463347 colon cancer 0.282697 Clin Oncol 0.692377 colorectal carcinoma 0.438634 resection 0.263133 colorectal carcinoma metastases 0.326025	CLICK HERE
1416	National Cancer Institute	Html	en	Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer.	relapsed ovarian cancer 0.50784 recurrent epithelial ovarian 0.499159 ovarian cancer symptom 0.524517 gynecologic cancer intergroup 0.468129 epithelial ovarian carcinoma 0.585917 chemotherapy 0.476196 Engl J Med 0.538958 advanced ovarian cancer 0.684932 advanced epithelial ovarian 0.546935 ovarian cancer FIGO 0.514859 ovarian cancer. 0.501481 [PUBMED Abstract] 0.522867 primary peritoneal cancer 0.467281 ovarian cancer patients 0.574798 ovarian cancer trials 0.513542 Ovarian Cancer Registry 0.525648 ovarian cancer 0.976385 oncology group study 0.500359 advanced ovarian epithelial 0.508108 ovarian carcinoma 0.617715 Hereditary ovarian cancer 0.541701 Natl Cancer Inst 0.533435 Clin Cancer Res 0.471625 Gynecol Oncol 0.499118 ovarian carcinoma patients 0.50527	et al. 0.626141 gynecologic oncology group 0.583453 Lancet Oncol 0.480848 refractory ovarian cancer 0.508349 ovarian cancer—is 0.495704 ovarian cancers 0.496625 II-IV ovarian cancer 0.51385 advanced ovarian carcinoma 0.5343 ovarian epithelial cancer 0.539908 residual ovarian cancer 0.518325 epithelial ovarian cancer 0.803483 ovarian cancer susceptibility 0.533409 Brady MF 0.481715 sporadic ovarian cancer 0.521614 Abstract 0.644778 Clin Oncol 0.718243 platinum-sensitive ovarian cancer 0.536106 BRCA2-associated ovarian cancer 0.521842 recurrent ovarian cancer 0.527704 serous ovarian cancer 0.529665 Ovarian Neoplasm Group 0.493177 advanced-stage ovarian cancer 0.537713 ovarian cancer screening 0.523447 ovarian cancer syndrome 0.536708	CLICK HERE
1500	National Cancer Institute	Html	en	Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of non-small cell lung cancer.	Lung Cancer Cooperative 0.310221 lung carcinoma 0.380451 inoperable lung cancer 0.309782 early non-small-cell lung 0.307115 advanced non-small-cell lung 0.469604 Lung Cancer Study 0.326026 lung cancer 0.971767 Lung cancer deaths 0.317514 nonsquamous non-small-cell lung 0.297343 phase iii trial 0.299266 occult lung cancer 0.305312 early-stage lung cancer 0.338843 Radiat Oncol Biol 0.304077 lung cancer survival 0.297734 Lung Cancer Group 0.321151 initial lung cancer 0.317764 Natl Cancer Inst 0.376584 non-small cell lung 0.774213 resectable lung cancer 0.304943 Cochrane Database Syst 0.296204 inoperable non-small-cell lung 0.308792 non-small cell carcinoma 0.303827 extensive-stage non-small-cell lung 0.295848 non-small-cell lung carcinoma 0.344111 IIIB/IV non-small-cell lung 0.298147	et al. 0.437141 Lancet Oncol 0.323758 metastatic non-small-cell lung 0.298496 advanced non-small cell 0.33334 stage lung cancer 0.3104 nonsmall cell lung 0.30317 stage non-small-cell lung 0.297284 PUBMED Abstract 0.329665 Ann Thorac Surg 0.373477 Lung Cancer Vinorelbine 0.296492 Thorac Cardiovasc Surg 0.329974 lung cancer patients 0.336644 Cancer Lung Cancer 0.319239 Abstract 0.497046 Clin Oncol 0.544028 cell lung carcinoma 0.373251 Oncol Biol Phys 0.305449 lung cancer risk 0.31701 non-squamous non-small-cell lung 0.296764 cell lung cancer 0.689155 IIIB non-small-cell lung 0.303595 Clin Lung Cancer 0.316476 resected non-small-cell lung 0.312654 oncology group 0.300833	CLICK HERE
1532	National Cancer Institute	Html	en	714-X (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of 714-X as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	peer-reviewed scientific journals 0.887587 follow-up treatment 0.710806 cancer cell growth 0.791188 clinical drug research 0.768994 transplanted lymphoma cells 0.825998 camphor-containing compound 0.745221 -dependent breast cancer 0.78236 Cancer Terms 0.744215 ammonia chloride moiety 0.76714 well-designed clinical trials 0.748928 IND application process 0.779791 normal cellular metabolism 0.86297 cancer information summary 0.831041 markets 714-X worldwide 0.83392 breast adenocarcinoma cells 0.816142 conventional light microscope 0.751864 high-magnification dark-field microscope 0.762305 single daily injection 0.759423 local radiation therapy 0.743305 Investigational New Drug 0.768167 estrone sulfatase activity 0.749881 radiation therapy 0.757461 usual treatment cycle 0.783702 immune system cells 0.780568 dead cells 0.766188	lymphoma tumor models 0.74615 treatment cycles 0.709107 peer-reviewed scientific journal 0.752325 breast cancer cells 0.935858 714-X states 0.744286 tumor cells 0.75621 camphor component 0.757515 secrete growth hormones 0.755571 cancer cells 0.999087 malignant cells 0.759464 lymphosarcoma tumor model 0.750284 714-X treatment. 0.746291 human breast cancer 0.781637 privately funded laboratory 0.780536 normal cells 0.757341 714-X state 0.740311 animal studies 0.738772 cancer development 0.726298 714-X reportedly works 0.811434 3-day rest period 0.75559 natural killer cells 0.815748 quality control procedures 0.767937 camphor vapors 0.863518 Numerous trace elements 0.765609	CLICK HERE
1667	National Cancer Institute	Html	en	Pituitary Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of pituitary tumors.	cancer treatment 0.407234 dexamethasone suppression test 0.394248 pituitary tumors 0.908358 body 0.454559 PDQ cancer information 0.487589 clinical trials 0.725513 cancer information summary 0.446379 clinical trial 0.553145 Invasive pituitary adenomas 0.455827 pituitary tumor 0.646868 treatment clinical trial 0.392398 PDQ Adult Treatment 0.388468 transsphenoidal surgery 0.460842 symptoms 0.386795 NCI PDQ cancer 0.400275 radiation therapy 0.593266 Treatment Editorial Board 0.409955 general cancer information 0.38362 treatment 0.554395 Pituitary Tumors Treatment 0.478882 magnetic resonance imaging 0.396976 hormones 0.440574 non-functioning pituitary tumor 0.50102 pituitary adenomas 0.476474	cancer cells 0.443241 pituitary gland 0.710758 Cancer Information Service 0.384842 pituitary carcinomas 0.478569 hormone 0.451928 treatment clinical trials 0.429229 National Cancer Institute 0.477993 spinal cord 0.43789 growth hormone 0.42514 lower sex drive 0.403907 new treatment 0.437528 drug therapy 0.42565 stereotactic radiation surgery 0.403899 Non-functioning pituitary tumors 0.494237 Benign pituitary adenomas 0.455748 nuclear magnetic resonance 0.398799 thyroid-stimulating hormone 0.404707 extra hormones 0.398825 cancer clinical trials 0.398461 recurrent pituitary tumor 0.483709 cancer information summaries 0.383614 functioning pituitary tumor 0.497093 comprehensive cancer information 0.383142 cancer 0.645719	CLICK HERE
1793	National Cancer Institute	Html	es	La nutrición en el tratamiento del cáncer (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y manejo de los problemas de nutrición que se presentan en pacientes de cáncer.	alimentos quizás 0.370325 PDQ Complicaciones 0.313282 siguientes procedimientos 0.340481 células madre 0.550599 nutrientes clave 0.335265 siguientes elementos 0.365852 siguientes aspectos 0.358365 nutriciónLa terapia 0.324031 siguientes especialistas 0.336855 abundantes calorías 0.314309 azúcar morena 0.306423 apoyo nutricional parenteral 0.676801 alimentos nombre 0.30449 plantas crucíferas 0.309965 nutriciónLos pacientes 0.345324 siguientes preguntas 0.30436 folleto consejos 0.305431 saliva espesa 0.32646 dentaduras postizas 0.314487 suficiente aire 0.303863 La nutrición 0.791013 paciente coma 0.327504 parenteralLa nutrición parenteral 0.367865	nutriciónLa radioterapia 0.32699 Nutrición enteralLa 0.344949 Fideos macarrones 0.304814 paciente debilidad 0.352763 nutriciónLa quimioterapia 0.324928 siguientes problemas 0.328941 abundantes proteínas 0.312201 abundante cantidad 0.303969 pequeñas cantidades 0.366387 suficientes calorías 0.337397 sección boca 0.313815 queso crema 0.306383 suficientes proteínas 0.348155 suficientes alimentos 0.437599 suficientes nutrientes 0.304871 estado nutricional ayuda 0.362928 huevos rellenos 0.30608 siguientes logros 0.337047 nutrición parenteral 0.929054 horarios fijos 0.305496 siguientes propósitos 0.338729 cuidado paliativo 0.310231	CLICK HERE
1815	National Cancer Institute	Html	es	Tratamiento del cáncer de cuello uterino (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de cuello uterino.	Obstet Gynecol 0.42996 stage iib-iva carcinoma 0.404466 Massad LS 0.404333 cervical carcinoma 0.464118 Bundy BN 0.406109 adenosquamous carcinomas 0.405376 Radiat Oncol Biol 0.406797 stage ib 0.417647 oncology group study 0.410713 Natl Cancer Inst 0.438413 cervical cancer 0.632715 advanced cervical carcinoma 0.414377 stage ib squamous 0.405131 Gynecologic Oncology Group 0.426077 Cervical stump carcinoma 0.407575 Gynecol Oncol 0.448646 patients with 0.420179 human papillomavirus 0.464727 early invasive carcinoma 0.40349 IB cervical carcinoma 0.422999 Lancet Oncol 0.403538 Castle PE 0.404079 adenosquamous cell carcinoma 0.403688 cervical cytology 0.405121 cervical smears as 0.405304	estadio ia 0.405069 squamous cell 0.407969 cervical carcinoma from 0.408556 Féderation Internationale 0.404624 Human papillomavirus type 0.404678 Cancer Institute Workshop 0.403618 cervix treated with 0.403584 estadio ia2 0.404118 medically inoperable carcinoma 0.403293 patients with stage 0.411753 Clin Oncol 0.421471 invasive cervical carcinoma 0.408099 cervical cancers studied 0.405438 Cervical Cancer Meta-Analysis 0.408283 Oncol Biol Phys 0.406905 with cervical carcinoma 0.410366 cervix with negative 0.403324 cervical intraepithelial neoplasia 0.500035 cuello uterino 0.989011 squamous intraepithelial lesions 0.406344 treated with 0.404461 locally advanced 0.404236 Wright TC Jr 0.413972 AJCC Cancer Staging 0.403712	CLICK HERE
2000	National Cancer Institute	Html	es	Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.	cuánto aire 0.415134 siguientes procedimientos 0.528715 células madre 0.858073 adultos jóvenes 0.464664 efectos secundarios meses 0.439126 siguientes aspectos 0.434701 faja ajustadora 0.428231 HCL infantil multisistémica 0.546722 cuántos sistemas 0.518567 genes ras 0.453948 pequeña cantidad 0.423844 células normales.ampliar exploración 0.532323 vía oral 0.42013 rayos x 0.425227 gen braf 0.666188 largo plazo 0.44968 cuántas células 0.518957 niño ayuda 0.426203 efectos tardíos 0.516221 escáner.ampliar exploración 0.429231 tarde.ampliar ecografía 0.427113	vías respiratorias 0.424871 causa problemas 0.424997 lesiones óseas 0.423193 National Cancer Institute 0.417904 IRMN).Ampliar Imágenes 0.421648 siguientes riesgos 0.415861 radiación uvb 0.414555 Instituto Nacional 0.431398 PDQ Tratamiento 0.451873 antecedentes familiares 0.589915 llamada genes ras 0.432872 explorador tep 0.430081 terapia fotodinámica causa 0.453098 sistema nervioso central 0.604707 Physician Data Query 0.464236 mayores probabilidades 0.416225 HCL multisistémica 0.966875 terapia fotodinámica llamada 0.451949 radiación ultravioleta 0.561342 siguientes pruebas 0.489919	CLICK HERE
3602	National Cancer Institute	Html	en	Improved Strategies for Cancer Prevention and Early Detection	The prevention of cancer and the development of more effective strategies to detect cancer precursors and early stage cancers, when treatment may be most effective, remain critical goals.	cancer treatment 0.540152 anal cancer incidence 0.625627 noncervical cancers 0.552703 preventive HCV vaccine 0.546412 research 0.535928 HPV-positive oropharyngeal cancers 0.555563 cancer biomarker discovery 0.573956 cancer develops 0.60048 cancer biomarker development 0.580329 early pancreatic disease 0.537001 smear-based cervical cancer 0.616538 chronic HCV infection 0.559892 colorectal cancer 0.576235 patients 0.541815 cervical cancer screening 0.699176 cervical cancers 0.57226 cervical cancer 0.761077 HPV vaccine program 0.571212 chronic HBV infection 0.541902 cancers 0.616554 HPV-positive oropharyngeal cancer 0.594068 oncogenic HPV types 0.574039 infectious EBV particles 0.546363 invasive anal cancer 0.592328 United States 0.811567	HCV infection 0.652225 pancreatic cancer precursor 0.587151 percent 0.591951 transfusion-related HCV infection 0.564422 pancreatic cancer 0.645751 precursor lesions 0.541991 common cancer 0.538917 pancreatic cancer cells 0.595973 virus-like particles 0.540706 early cancer detection 0.576023 disease 0.540607 healthy donors 0.556987 persistent HPV infection 0.586925 breast cancer 0.583768 liver cancer mortality 0.588652 late-stage cancer 0.546609 HPV infection 0.707275 cancer risk 0.57351 lung cancer incidence 0.625104 cancer 0.986132 liver cancer 0.648599 Earlier cancer detection 0.569503 EBV infection 0.614356 cancer incidence 0.636488	CLICK HERE
16683	National Cancer Institute	Html	es	714-X (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Alternative Medicine Confronts 0.349 Task Force 0.681834 Rock Forest 0.4465 Cancer Research Initiative 0.920081 Radiosensitizing effect 0.323708 but not 0.32369 Goel HC 0.323157 Alternative Therapeutic 0.727518 Bacteria Cause Cancer 0.362108 Unconventional therapies 0.71198 Breast Cancer Research 0.913503 saccharin-LiCl conditioned stimulus 0.34146 Roa AR 0.322774 transplantable mammary 0.323668 Instituto Nacional 0.49296 Pharmacol Biochem Behav 0.342417 Pavlovian conditioning 0.324132 PDQ 714-X 0.384196 posibles efectos 0.32412 Estados Unidos 0.547224 Canadian Breast Cancer 0.923206 for bacteria as 0.342644 vía nasal 0.324957 Purohit A 0.322533 New York University 0.333776	alcanfor mejora 0.352671 Conditioned enhancement 0.324112 linfoma caninos 0.323743 CERBE Distribution 0.468077 Solvason HB 0.367895 Hiramoto RN 0.325133 new approach 0.322794 empresa distribuidora 0.324674 National Cancer Institute 0.431242 Hiramoto NS 0.502986 vitamina b12 0.324597 New York 0.3535 accessed april 0.467486 Neurosci Res 0.325453 numerosos oligoelementos 0.325391 Physician Data Query 0.337084 Hess DJ 0.368799 libre uso 0.325033 linfosarcoma murinos 0.323938 Ghanta VK 0.432317 cartílago bovino 0.325426 killer cell activity 0.342736 response to yc8 0.339588 Soong SJ 0.323559	CLICK HERE